Target intelligence / Profile preview

Hemagglutinin of Influenza A Virus Subtype H5 (None)

Target
None
Molecular classification
Class I viral fusion glycoprotein, Type I transmembrane glycoprotein
01

Overview

Hemagglutinin (HA) is a surface glycoprotein and the principal antigenic determinant of influenza A viruses, including subtype H5. It is responsible for binding the virus to host cell receptors and mediating membrane fusion during viral entry. The HA protein exists as a trimer on the viral envelope and undergoes significant conformational changes to facilitate infection. Mutations in or near the receptor-binding domain can alter species specificity, enabling binding to human-type receptors and facilitating zoonotic transmission potential. The pathogenicity of highly pathogenic avian influenza (HPAI) viruses like some H5N1 strains is closely linked to specific motifs at the HA cleavage site.

Other names
HAH5 hemagglutininInfluenza A H5 hemagglutininH5 HA
02

Mechanism of action

Binding to sialic acid receptors on host cells; mediating fusion between viral and endosomal membranes

03

Biological functions

Receptor bindingMembrane fusionViral entryImmune evasion
04

Disease associations

InfectionInfluenzaAvian influenzaZoonotic diseasePandemic potential
05

Safety considerations

High pathogenicity of some strains (e.g., H5N1)Potential for zoonotic transmissionRisk of pandemic due to mutations enabling human-to-human transmissionAntigenic drift and shift leading to vaccine escape

Beyond the preview

Go deeper on Hemagglutinin of Influenza A Virus Subtype H5 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin of Influenza A Virus Subtype H5 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call